Search Results - "Niemann, C. U."

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation by Malcikova, J., Tausch, E., Rossi, D., Sutton, L. A., Soussi, T., Zenz, T., Kater, A. P., Niemann, C. U., Gonzalez, D., Davi, F., Gonzalez Diaz, M., Moreno, C., Gaidano, G., Stamatopoulos, K., Rosenquist, R., Stilgenbauer, S., Ghia, P., Pospisilova, S.

“…In chronic lymphocytic leukemia (CLL), TP53 gene defects, due to deletion of the 17p13 locus and/or mutation(s) within the TP53 gene, are associated with…”
Get full text

Liver Transplantation Outcome in Patients With Angiographically Proven Coronary Artery Disease: A Multi‐Institutional Study by Wray, C., Scovotti, J. C., Tobis, J., Niemann, C. U., Planinsic, R., Walia, A., Findlay, J., Wagener, G., Cywinski, J. B., Markovic, D., Hughes, C., Humar, A., Olmos, A., Sierra, R., Busuttil, R., Steadman, R. H.

“…Over the last decade the age of liver transplant (LT) recipients and the likelihood of coronary artery disease (CAD) in this population have increased. There…”
Get full text

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial by Pettengell, R., Uddin, R., Boumendil, A., Johnson, R., Metzner, B., Martín, A., Romejko-Jarosinska, J., Bence-Bruckler, I., Giri, P., Niemann, C. U., Robinson, S. P., Kimby, E., Schmitz, N., Dreger, P., Goldstone, A. H., Montoto, S.

“…We report the 12-year follow-up of the prospective randomized EBMT LYM1 trial to determine whether the benefit of brief duration rituximab maintenance (RM) on…”
Get full text

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Eichhorst, B., Robak, T., Montserrat, E., Ghia, P., Niemann, C.U., Kater, A.P., Gregor, M., Cymbalista, F., Buske, C., Hillmen, P., Hallek, M., Mey, U.

“…•These updated ESMO Clinical Practice Guidelines provide key recommendations on the management of chronic lymphocytic leukaemia (CLL)•Authorship includes a…”
Get full text

Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia by NIEMANN, C. U, KJELDSEN, L, RALFKIAER, E, JENSEN, M. K, BORREGAARD, N

“…Serglycin is the major cell-associated proteoglycan of hematopoietic cells. Previous work has demonstrated that serglycin may be involved in targeting some…”
Get full text

Protecting the Kidney in Liver Transplant Recipients: Practice‐Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice by Levitsky, J., O'Leary, J. G., Asrani, S., Sharma, P., Fung, J., Wiseman, A., Niemann, C. U.

“…Both acute and chronic kidney disease are common after liver transplantation and result in significant morbidity and mortality. The introduction of the Model…”
Get full text

ESMO Clinical Practice Guideline interim update on new targeted therapies in the first line and at relapse of chronic lymphocytic leukaemia by Eichhorst, B, Ghia, P, Niemann, C U, Kater, A P, Gregor, M, Hallek, M, Jerkeman, M, Buske, C

Get more information

Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood by Herndon, T M, Chen, S-S, Saba, N S, Valdez, J, Emson, C, Gatmaitan, M, Tian, X, Hughes, T E, Sun, C, Arthur, D C, Stetler-Stevenson, M, Yuan, C M, Niemann, C U, Marti, G E, Aue, G, Soto, S, Farooqui, M Z H, Herman, S E M, Chiorazzi, N, Wiestner, A

“…Chronic lymphocytic leukemia (CLL) is a progressive malignancy of mature B-cells that involves the peripheral blood (PB), lymph nodes (LNs) and bone marrow…”
Get full text

Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study by Herman, S E M, Niemann, C U, Farooqui, M, Jones, J, Mustafa, R Z, Lipsky, A, Saba, N, Martyr, S, Soto, S, Valdez, J, Gyamfi, J A, Maric, I, Calvo, K R, Pedersen, L B, Geisler, C H, Liu, D, Marti, G E, Aue, G, Wiestner, A

“…Ibrutinib and other targeted inhibitors of B-cell receptor signaling achieve impressive clinical results for patients with chronic lymphocytic leukemia (CLL)…”
Get full text

EPCORITAMAB MONOTHERAPY AND COMBINATIONS IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA OR RICHTER’S SYNDROME: NEW ESCALATION AND EXPANSION COHORTS IN EPCORE CLL‐1 by Eichhorst, B., Eradat, H., Niemann, C. U., Oki, T., Kuznetsova, A., Rios, M., Valentin, R., Kater, A. P.

Get full text

Improved survival for patients diagnosed with chronic lymphocytic leukemia in the era of chemo-immunotherapy: a Danish population-based study of 10455 patients by da Cunha-Bang, C, Simonsen, J, Rostgaard, K, Geisler, C, Hjalgrim, H, Niemann, C U

“…The treatment of chronic lymphocytic leukemia (CLL) is in rapid transition, and during recent decades both combination chemotherapy and immunotherapy have been…”
Get full text

The Impact of Hydroxyethyl Starch Use in Deceased Organ Donors on the Development of Delayed Graft Function in Kidney Transplant Recipients: A Propensity‐Adjusted Analysis by Patel, M. S., Niemann, C. U., Sally, M. B., De La Cruz, S., Zatarain, J., Ewing, T., Crutchfield, M., Enestvedt, C. K., Malinoski, D. J.

“…Our objective was to evaluate the impact of hydroxyethyl starch (HES) use in organ donors after neurologic determination of death (DNDD) on recipient renal…”
Get full text

P1596: PREDIAGNOSTIC ANTIMICROBIAL USE IN CLL, MM, FL AND DLBCL by Packness, E. M., Andersen, M. A., Rostgaard, K., Hjalgrim, H., Niemann, C. U., Brieghel, C.

Get full text

Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores by Niemann, C. U., Behrends, M., Quan, D., Eilers, H., Gropper, M. A., Roberts, J. P., Hirose, R.

“…Patients undergoing orthotopic liver transplantation (OLT) often experience significant coagulopathy and remain at risk for excessive blood loss and massive…”
Get full text

THE CLL‐RT1 TRIAL: A MULTICENTER PHASE‐2 TRIAL OF ZANUBRUTINIB, A BTK INHIBITOR, PLUS TISLELIZUMAB, A PD‐1 INHIBITOR, FOR PATIENTS WITH RICHTER TRANSFORMATION by Al‐Sawaf, O., Robrecht, S., Stumpf, J., Fink, A.‐M., Ritgen, M., Johansson, P., Tausch, E., Hoechstetter, M., Staber, P., Jäger, U., Niemann, C. U., Pallasch, C., Kreuzer, K.‐A., Stilgenbauer, S., Fischer, K., Wendtner, C., Hallek, M., Eichhorst, B.

Get full text

Ischemic preconditioning improves rat kidney graft function after severe ischemia/reperfusion injury by Fuller, T.F., Freise, C.E., Feng, S., Niemann, C.U.

“…Ischemic preconditioning (IP) has been shown to ameliorate renal ischemia reperfusion injury. Using a rat kidney transplantation model we determined if IP…”
Get full text

P1264: HEMATOPOIETIC CLONES WITH TP53 MUTATIONS EXPAND IN PATIENTS WITH MCL DURING LENALIDOMIDE‐BASED THERAPY by Husby, S., Bæch‐Laursen, C., Favero, F., Jespersen, J. S., Eskelund, C. W., Hutchings, M., Pedersen, L. B., Niemann, C. U., Weischenfeldt, J., Geisler, C., Räty, R., Larsen, T. S., Kolstad, A., Jerkeman, M., Grønbæk, K.

Get full text

Intraoperative fluid management of living donor versus cadaveric liver transplant recipients by Niemann, C.U, Hirose, R, Stock, P, Roberts, J.P, Mandell, S, Spencer Yost, C

“…Living donor liver transplantation has increasingly become an alternative to cadaveric donor liver transplants for select adult patients. Because these cases…”
Get full text

Liver transplant perioperative pathways: which way towards high-quality care and better outcomes? by Biancofiore, G, Niemann, C U

Get full text

Abdominal organ transplantation by Niemann, C U, Eilers, H

“…The improvement in the success of solid organ transplantation over the past decades is remarkable and well documented. It is now a well-accepted treatment…”
Get full text